Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 150 publications
Real-World Outcomes of Ipilimumab-Nivolumab vs. Anti-PD-1 Monotherapy in Metastatic Uveal Melanoma: A Single-Center Retrospective Study.
Journal: Cancers
Published: September 25, 2025
Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8.
Journal: International journal of molecular sciences
Published: September 21, 2025
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers.
Journal: Seminars in hematology
Published: August 21, 2025
Montelukast as a novel therapeutic approach in metastatic uveal melanoma harboring a CYSLTR2 mutation: a translational case report.
Journal: ESMO open
Published: August 13, 2025
Bispecific immunotherapy based on antibodies, T-cell receptors, and aptamers: mechanisms of action, adverse effects, and future perspectives.
Journal: Frontiers in immunology
Published: August 04, 2025
Tebentafusp in Metastatic Uveal Melanoma: A Meta-analysis.
Journal: Targeted oncology
Published: August 04, 2025
Comment on: "Tebentafusp Versus Nivolumab Plus Ipilimumab for Metastatic Uveal Melanoma: An E‑Value Sensitivity Analysis Assessing Effect of Unmeasured Confounders on Observational Associations".
Journal: Clinical drug investigation
Published: July 24, 2025
Response to Comment on: "Tebentafusp Versus Nivolumab Plus Ipilimumab for Metastatic Uveal Melanoma: An E-Value Sensitivity Analysis Assessing Effect of Unmeasured Confounders on Observational Associations".
Journal: Clinical drug investigation
Published: July 24, 2025
Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis.
Journal: Frontiers in oncology
Published: July 16, 2025
Artificial intelligence-assisted assessment of metabolic response to tebentafusp in metastatic uveal melanoma: a long axial field-of-view [18F]FDG PET/CT study.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 02, 2025
Circulating tumor DNA is prognostic of patient outcome and enables therapy monitoring in metastatic uveal melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 18, 2025
Last Updated: 01/07/2026